Papillomavirus-Induced Oncogenesis: Current Insights and Future Directions

Dear Colleagues,

Papillomaviruses (PVs) encompass a diverse family of viruses, with over 100 identified types, 13 of which are recognized as carcinogenic. These viruses have been implicated in a range of oncogenic processes across various anatomical sites, presenting a complex area of study within the field of virology and oncology. Understanding the underlying mechanisms and clinical implications of papillomavirus-induced oncogenesis is thus of paramount importance.

This Special Issue aims to provide a comprehensive platform for the exploration of current insights and future directions in papillomavirus-induced oncogenesis. We invite contributions covering a wide array of topics, including but not limited to:

• Elucidating the molecular and cellular mechanisms underpinning papillomavirus-induced oncogenesis, spanning a diverse range of anatomical sites;
• Advances in the development and application of diagnostic tools and techniques for detecting papillomavirus infections and associated malignancies;
• Epidemiological studies and analyses of trends in papillomavirus-associated cancers, providing critical insights into the global burden of these malignancies;
• Innovative therapeutic approaches, including immunotherapies, targeted interventions, and the exploration of potential biomarkers for personalized treatment strategies;
• Evaluation of vaccination against papillomaviruses, assessing their impact on prevention, risk reduction, and potential applications beyond established indications.

We welcome contributions from researchers, clinicians, and experts in the field, with the aim of fostering a comprehensive understanding of the complex interplay between papillomaviruses and oncogenesis across diverse anatomical contexts. Muharrem Okan Cakir will provide valuable support to the co-editor and editors by participating in manuscript reviews, facilitating effective communication with reviewers, ensuring the maintenance of quality standards, and collating reviewer comments. Additionally, he will be involved in communicating the final decision to the corresponding author. Together, we endeavor to advance knowledge in this critical area of virology and oncology.

Dr. G. Hossein Ashrafi
Prof. Dr. Mustafa Ozdogan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.